Prescriptions of risedronate sodium doubled up while alendronate sodium dropped

Published: 2015-11-20 16:13:43

Updated: 2015-11-20 16:13:43

A research was revealed to study an aspect of prescription changes among bisophosphonate-type single drugs which have led the osteoporosis treatment market.

While a prescription rate of risedronate(original: Actonel), the new bisophosphonate agent, doubled up between 2008 and 2012, the one of alendronate(original: Fosamax) was decreased by 32%.

Professor Sun-mi Jang of College of Pharmacy, Ga...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.